The store will not work correctly when cookies are disabled.
4-[3-(4-Methylphenyl)-5-ethyl-5-methyl-4-oxo-2-thioxoimidazolidin-1-yl]-2-trifluoromethylbenzonitrile
ID: ALA1086363
PubChem CID: 46889903
Max Phase: Preclinical
Molecular Formula: C21H18F3N3OS
Molecular Weight: 417.46
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCC1(C)C(=O)N(c2ccc(C)cc2)C(=S)N1c1ccc(C#N)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C21H18F3N3OS/c1-4-20(3)18(28)26(15-8-5-13(2)6-9-15)19(29)27(20)16-10-7-14(12-25)17(11-16)21(22,23)24/h5-11H,4H2,1-3H3
Standard InChI Key: SIPHQNDZYLBGMW-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 31 0 0 0 0 0 0 0 0999 V2000
-2.8346 -12.8158 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8357 -13.6431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1210 -14.0560 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4046 -13.6426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4074 -12.8122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1228 -12.4031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5503 -12.3977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2647 -11.9854 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.5505 -14.0550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2646 -13.6420 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.5512 -14.8799 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-3.7634 -13.2580 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
-0.7370 -14.1196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7297 -14.9445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0572 -15.1925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5362 -14.5209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0453 -13.8578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2933 -13.0711 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.3600 -14.5119 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7799 -15.2242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6048 -15.2157 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0109 -14.4957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5859 -13.7827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7624 -13.7946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8359 -14.4858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3190 -15.9748 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.5582 -14.9407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7375 -15.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3208 -16.3490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7 8 3 0
1 7 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
4 13 1 0
17 18 2 0
16 19 1 0
2 9 1 0
4 5 1 0
19 20 2 0
9 10 1 0
20 21 1 0
2 3 1 0
21 22 2 0
9 11 1 0
22 23 1 0
5 6 2 0
23 24 2 0
24 19 1 0
9 12 1 0
22 25 1 0
13 14 1 0
15 26 2 0
6 1 1 0
14 27 1 0
1 2 2 0
14 28 1 0
3 4 2 0
28 29 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.46 | Molecular Weight (Monoisotopic): 417.1123 | AlogP: 5.19 | #Rotatable Bonds: 3 |
Polar Surface Area: 47.34 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 5.97 | CX LogD: 5.97 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.64 | Np Likeness Score: -1.16 |
References
1. Jung ME, Ouk S, Yoo D, Sawyers CL, Chen C, Tran C, Wongvipat J.. (2010) Structure-activity relationship for thiohydantoin androgen receptor antagonists for castration-resistant prostate cancer (CRPC)., 53 (7): [PMID:20218717] [10.1021/jm901488g] |